Compositions and methods for weight loss in at risk patient populations

• 收藏
• 分享

专利权人:

Inc.;Orexigen Therapeutics

发明人:

Preston Klassen,Kristin Taylor

申请号：

US14635518

公开号：

US09119850B2

申请日:

2015.03.02

申请国别(地区):

US

年份:

2015

代理人:

摘要：

The present disclosure relates to compositions, kits, uses, systems and methods related to naltrexone plus bupropion for treating an overweight or obese subject at increased risk of adverse cardiovascular outcomes. Preferably, the subject has had type-two diabetes for a period of less than 6 years or is a current smoker, optionally that does not have type-two diabetes.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/